New Delhi: On the one hand, while the second wave of corona in the country is gradually weakening, on the other hand, speculations are also being made about the third wave. According to experts, the third wave of corona can knock in India soon. Along with this, some experts and studies are telling that children are more likely to be affected in the third wave. In the midst of all this, big information has come to the fore regarding the vaccine of children.
Delhi AIIMS Hospital director Dr. Randeep Guleria has said that Bharat Biotech’s covaccine can be approved for children by September. Dr. Guleria said, “The data will be available by September after the Phase II and III trials of Covaccine on children. Along with this, he said that if Pfizer-BioNtech is approved in India, then it can also be an alternative to a vaccine for children.
Let us inform that in AIIMS Patna and AIIMS Delhi, the trial of covaccine is going on on children between the age of two to 12 years. On May 12, DCGI approved Bharat Biotech for Phase II and III trials on children.
However, Dr. Guleria denied that children are more likely to be affected in the third wave. He said that there is no reason to believe in this theory. Let us tell you that recently, WHO and AIIMS together did a sero survey.
According to the findings of this survey, children are not likely to be affected much more than adults. The study was conducted in five selected states with a proposed population of 10,000.
Along with this, Dr. Guleria also asked to consider opening children’s schools, although he said that we also have to decide that educational institutions do not become super spreaders of Corona.
Corona Update: So far 3 crore people have been infected across the country, more than 50 thousand new cases have come in 24 hours
Congress raised questions on record vaccination on June 21, Chidambaram said – hoarding done to make records